# reload+after+2024-01-20 19:46:08.123778
address1§9301 Amberglen Boulevard
address2§Suite 100
city§Austin
state§TX
zip§78729
country§United States
phone§512 869 1555
website§https://www.mtem.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company primarily develops therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
fullTimeEmployees§111
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Eric E. Poma Ph.D.', 'age': 51, 'title': 'CEO, Chief Scientific Officer & Director', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 923340, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jason S Kim', 'age': 48, 'title': 'President, CFO, Treasurer & Principal Accounting Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 639846, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kristen  Quigley B.A.', 'age': 52, 'title': 'Chief Operating Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Grace  Kim', 'title': 'Chief Strategy Officer & Head of IR', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Joseph  Phillips Ph.D.', 'title': 'Senior VP & Head of CMC Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Maurizio  Voi M.D.', 'age': 65, 'title': 'Chief Medical Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Megan C. Filoon', 'title': 'Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§7
compensationRisk§7
shareHolderRightsRisk§5
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.236
priceToSalesTrailing12Months§0.35048926
currency§USD
dateShortInterest§1702598400
forwardEps§-3.41
pegRatio§-0.41
exchange§NCM
quoteType§EQUITY
shortName§Molecular Templates, Inc.
longName§Molecular Templates, Inc.
firstTradeDateEpochUtc§1107527400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§50b78e85-ce75-3e81-80ea-f799bd42f2e1
gmtOffSetMilliseconds§-18000000
targetHighPrice§18.0
targetLowPrice§15.0
targetMeanPrice§16.5
targetMedianPrice§16.5
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§2
quickRatio§0.735
grossMargins§-0.090129994
ebitdaMargins§-0.355
trailingPegRatio§None
